Turning Heads: The Vanderbilt Brain Institute has emerged as a hub of discovery as neuroscience’s influence expands
Aug. 5, 2020—The VBI recently marked its 20th anniversary, a span that has seen the institute’s wide-ranging missions—including administering the university’s Neuroscience Graduate Program, as well as postdoctoral training and community outreach—steadily coalesce under a single umbrella.
Mar. 13, 2019—A special lecture by Randy Blakely, Ph.D., executive director FAU Brain Institute kicks off activities celebrating Brain Awareness Month at Vanderbilt. Blakely’s talk, “When Cocaine Just Won’t Do: ADHD and Serotonin-Dopamine Crosstalk,” will be held Thursday, March 14, 10 a.m., in 214 Light Hall. Vanderbilt graduate students worked with faculty advisors to develop a series...
May. 10, 2018—David Robertson, MD, second from left, poses with three longtime colleagues who spoke during last week’s symposium honoring his scientific legacy.
Dec. 16, 2016—Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.
Apr. 28, 2016—Researchers at Columbia and Vanderbilt universities have made an important discovery in mice that has implications for understanding the gastrointestinal (GI) problems experienced by some children with autism.
Apr. 21, 2016—Meagan Quinlan, a Pharmacology graduate student in the laboratory of Randy Blakely, Ph.D., honored her mentor Tuesday during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall.
Mar. 9, 2016—A new animal model can be used to “dissect” the inflammatory response to infection.
Nov. 5, 2015—Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.
Jul. 7, 2015—The partnership with Fisk through the Fisk-Vanderbilt Masters-to-PhD Bridge Program and other avenues, “presents us with an opportunity to see the results of our efforts impact an under-served community."
Feb. 11, 2015—The lab of Randy Blakely, Allan D. Bass Professor of Pharmacology and Psychiatry, has been named winner of the 2015 Vanderbilt Basketball Sustainability Competition.
Oct. 23, 2014—The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.
Sep. 4, 2014—Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder.